Sign In

Elizabeth (Betty) Suh-Burgmann, MD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

510-891-3400  (phone)


​ Elizabeth (Betty) Suh-Burgmann, MD, a gynecologic oncologist with The Permanente Medical Group, is an Adjunct Investigator with the Division of Research and a physician researcher with the Delivery Science & Applied Research Physician Researcher Program. Dr. Suh-Burgmann received her undergraduate degree at Cornell University and completed medical school and residency training at the University of California, San Francisco. She continued her training with a gynecologic oncology fellowship at Harvard Medical School/Massachusetts General Hospital.

Dr. Suh-Burgmann joined The Permanente Medical Group in 2000 and became a member of the Physician Researcher Program in 2017. Her research encompasses a diverse range of topics related to women’s cancers, including cancer and precancer of the uterus, borderline tumors of the ovary, ultrasound detection of ovarian cancer, and cervical cancer screening.

Current Position(s):

Section Affiliations:

  • Women’s and Children’s Health
  • Cancer
  • Health Care Delivery and Policy

Primary Research Interests:

  • Cancer and precancer of the uterus
  • Borderline tumors of the ovary
  • Ultrasound detection of ovarian cancer
  • Cervical cancer screening

    Implementation of large-scale HPV self-testing for cervical cancer screening

    The goal of this project is to determine the best strategy for integrating a home-testing option for cervical cancer screening. The most sensitive screening test for cervical cancer and precancer is a PCR-based test for human papilloma virus (HPV), which was adopted in June 2020 as the primary screening method for women aged 25-64.  Several large clinical trials have demonstrated the samples self-collected by patients for HPV testing are as accurate as samples collected by clinicians.  The project aims to assess the acceptability and overall effectiveness of HPV self-testing using a prospective pragmatic cluster-randomized design. The study results will inform which patients are most likely to benefit from a home-testing strategy and factors that influence uptake and completion of screening.
    Investigator: Suh-Burgmann, Betty
    Funder: The Permanente Medical Group

    Standardized ultrasound-based risk stratification for detection of ovarian cancer

    This project, initiated in 2014, led to the development and large-scale implementation of a system for risk stratifying ovarian abnormalities seen on ultrasound to ensure that similar abnormalities are described in a similar way by radiologists. The system also allows clinical management to be consistent from patient to patient and aligned with actual ovarian cancer risk. A 2016 study showed the reporting categories defined by the system correlate with distinct levels of ovarian cancer risk. We are currently investigating the risks associated with specific ultrasound characteristics in a low-risk community-based population and how to improve the system to ensure prompt diagnosis of ovarian cancer while avoiding unnecessary surgery for women with benign ovarian cysts.
    Investigator: Suh-Burgmann, Betty
    Funder: The Permanente Medical Group
    No results found matching criteria

    Ultrasound characteristics of early stage high-grade serous ovarian cancer

    Author(s): Suh-Burgmann E; Brasic N; Jha P; Hung YY; Goldstein RB

    Am J Obstet Gynecol. 2021 May 13.

    PubMed abstract

    Endometrial Cancer Detection During the Coronavirus Disease 2019 (COVID-19) Pandemic

    Author(s): Suh-Burgmann EJ; Alavi M; Schmittdiel J

    Obstet Gynecol. 2020 Jul 21.

    PubMed abstract

    Reservations Regarding O-RADS Recommendations

    Author(s): Suh-Burgmann E; Flanagan T; Brasic N

    Radiology. 2020 Feb 25:192559.

    PubMed abstract

    Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study

    Author(s): Powell CB; Littell RD; Landen CN; Pramanik S; Hamilton IC; Suh-Burgmann EJ

    Gynecol Oncol. 2020 Jan 07.

    PubMed abstract

    Outcomes of Robotic Hysterectomy for Treatment of Benign Conditions: Influence of Patient Complexity

    Author(s): Herrinton LJ; Raine-Bennett T; Liu L; Alexeeff SE; Ramos W; Suh-Burgmann B

    Perm J. 2020;24. Epub 2019-12-18.

    PubMed abstract

    Detection of early stage ovarian cancer in a large community cohort

    Author(s): Suh-Burgmann EJ; Alavi M

    Cancer Med. 2019 Sep 30.

    PubMed abstract

    Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting.

    Author(s): Levine D; Suh-Burgmann EJ; Brown DL; et al.

    Radiology. 2019 Nov;293(2):359-371. doi: 10.1148/radiol.2019191354. Epub 2019 Sep 24.

    PubMed abstract

    Lack of Standardized Terminology in Ultrasound Reports for Ovarian Cysts

    Author(s): Suh-Burgmann E; Herrinton L

    JAMA Intern Med. 2019 06 01;179(6):847-848.

    PubMed abstract

    Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System

    Author(s): Suh-Burgmann E; Flanagan T; Osinski T; Alavi M; Herrinton L

    Obstet Gynecol. 2018 11;132(5):1101-1111.

    PubMed abstract

    Large-Scale Implementation of Structured Reporting of Adnexal Masses on Ultrasound

    Author(s): Suh-Burgmann EJ; Flanagan T; Lee N; Osinski T; Sweet C; Lynch M; Caponigro M; Mehta J; Alavi M; Herrinton LJ

    J Am Coll Radiol. 2018 May;15(5):755-761. Epub 2018-03-20.

    PubMed abstract

    Prospective Case-Control Study of Abnormal Bleeding after Outpatient Corticosteroid Injection

    Author(s): Suh-Burgmann E; Liu JY

    Gynecol Obstet Invest. 2016 Nov 23.

    PubMed abstract

    The Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer

    Author(s): Suh-Burgmann E; Kinney W

    Front Oncol. 2016;6:25. Epub 2016-02-10.

    PubMed abstract

    Potential harms outweigh benefits of indefinite monitoring of stable adnexal masses

    Author(s): Suh-Burgmann E; Kinney W

    Am J Obstet Gynecol. 2015 Dec;213(6):816.e1-4. Epub 2015-09-09.

    PubMed abstract

    Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50

    Author(s): Suh-Burgmann E; Hung YY; Kinney W

    Am J Obstet Gynecol. 2014 Dec;211(6):623.e1-7. Epub 2014-07-25.

    PubMed abstract

    Abnormal vaginal bleeding after epidural steroid injection: a paired observation cohort study

    Author(s): Suh-Burgmann E; Hung YY; Mura J

    Am J Obstet Gynecol. 2013 Sep;209(3):206.e1-6. Epub 2013 Jun 28.

    PubMed abstract

    The value of additional pathology comments indicating suspicion of adenocarcinoma among women diagnosed preoperatively with complex atypical endometrial hyperplasia

    Author(s): Suh-Burgmann E; Hung YY; Armstrong MA

    Int J Gynecol Pathol. 2012 May;31(3):222-6.

    PubMed abstract

    Preservation of fertility after partial resection of bilateral ovarian cystadenofibromas: a case report

    Author(s): Ewing TL; Suh-Burgmann B

    J Reprod Med. 2011 Jul-Aug;56(7-8):364-5.

    PubMed abstract

    Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage

    Author(s): Suh-Burgmann E; Hung YY; Armstrong MA

    Obstet Gynecol. 2009 Sep;114(3):523-9.

    PubMed abstract

    Cytoreductive surgery for gynecologic malignancies--new standards of care

    Author(s): Suh-Burgmann E; Powell CB

    Surg Oncol Clin N Am. 2007 Jul;16(3):667-82, x-xi.

    PubMed abstract

    Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study

    Author(s): Suh-Burgmann E

    Gynecol Oncol. 2006 Dec;103(3):841-7. Epub 2006 Jun 21.

    PubMed abstract

    Risk factors for cervical stenosis after loop electrocautery excision procedure.

    Author(s): Suh-Burgmann EJ; Whall-Strojwas D; Chang Y; Hundley D; Goodman A

    Obstet Gynecol. 2000 Nov;96(5 Pt 1):657-60.

    PubMed abstract

    Surveillance for endometrial cancer in women receiving tamoxifen.

    Author(s): Suh-Burgmann EJ; Goodman A

    Ann Intern Med. 1999 Jul 20;131(2):127-35. doi: 10.7326/0003-4819-131-2-199907200-00009.

    PubMed abstract

    Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway.

    Author(s): Jones DL; Thompson DA; Suh-Burgmann E; Grace M; Munger K

    Virology. 1999 Jun 5;258(2):406-14. doi: 10.1006/viro.1999.9733.

    PubMed abstract

    Atypical squamous cells of undetermined significance: management patterns at an academic medical center.

    Author(s): Suh-Burgmann E; Darragh T; Smith-McCune K

    Am J Obstet Gynecol. 1998 May;178(5):991-5. doi: 10.1016/s0002-9378(98)70537-x.

    PubMed abstract